Paul Adams - Anthera Pharmaceuticals VP Compliance
| ANTHDelisted Stock | USD 0.0001 0.00 0.00% |
Insider
Paul Adams is VP Compliance of Anthera Pharmaceuticals
| Age | 60 |
| Phone | 410 350 1839 |
| Web | https://www.anthera.com |
Anthera Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (1.4196) % which means that it has lost $1.4196 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.6885) %, meaning that it created substantial loss on money invested by shareholders. Anthera Pharmaceuticals' management efficiency ratios could be used to measure how well Anthera Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Isabelle Lefebvre | Eyepoint Pharmaceuticals | N/A | |
| Steven Chan | Connect Biopharma Holdings | 52 | |
| Judith Moore | AC Immune | N/A | |
| MBA MD | Cullinan Oncology LLC | 51 | |
| Raul Collazo | Connect Biopharma Holdings | N/A | |
| Steve Andre | Cullinan Oncology LLC | N/A | |
| Elizabeth Wolffe | Synlogic | N/A | |
| Adam Thomas | Synlogic | N/A | |
| Jay MD | Eyepoint Pharmaceuticals | 65 | |
| James Balkovec | Cidara Therapeutics | N/A | |
| Malinda Longphre | Connect Biopharma Holdings | N/A | |
| Lei Sun | Connect Biopharma Holdings | 60 | |
| Carol Waldo | Cidara Therapeutics | N/A | |
| Jennifer Leonard | Eyepoint Pharmaceuticals | N/A | |
| MPH MD | Connect Biopharma Holdings | 54 | |
| Jeffrey Welch | GeoVax Labs | N/A | |
| Michael Jensen | Synlogic | N/A | |
| George Elston | Eyepoint Pharmaceuticals | 59 | |
| Jennifer Michaelson | Cullinan Oncology LLC | 57 | |
| CPA CPA | GeoVax Labs | 62 | |
| Maurice Zauderer | Vaccinex | 78 | |
Management Performance
| Return On Equity | -5.69 | ||||
| Return On Asset | -1.42 |
Anthera Pharmaceuticals Leadership Team
Elected by the shareholders, the Anthera Pharmaceuticals' board of directors comprises two types of representatives: Anthera Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anthera. The board's role is to monitor Anthera Pharmaceuticals' management team and ensure that shareholders' interests are well served. Anthera Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anthera Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bradley Esq, Sec | ||
| May Liu, Principal Accounting Officer, Compliance Officer and Sr. VP of Fin. and Admin. | ||
| Paul Adams, VP Compliance | ||
| Joshua Caldwell, Chief Officer | ||
| MBA MBA, Ex Chairman | ||
| Charles DSc, Advisor | ||
| Klara DickinsonEason, Advisor | ||
| John Thompson, CEO Director |
Anthera Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Anthera Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -5.69 | ||||
| Return On Asset | -1.42 | ||||
| Current Valuation | (7.47 M) | ||||
| Shares Outstanding | 26.18 M | ||||
| Number Of Shares Shorted | 2.02 M | ||||
| Price To Earning | (0.20) X | ||||
| Price To Book | 0.11 X | ||||
| Gross Profit | (28.49 M) | ||||
| EBITDA | (26.59 M) | ||||
| Net Income | (26.87 M) |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Anthera Pink Sheet
If you are still planning to invest in Anthera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anthera Pharmaceuticals' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |